By supporting many types of clinical trials, this funding will help turn research discoveries into real medical care faster – so children can benefit from new and innovative treatments sooner.

This study aims to improve rapid genomic testing for infants with low muscle tone. Currently, only about half of affected babies receive a diagnosis, meaning many miss out on targeted care.

Generation Victoria, or GenV, is Australia’s largest child and parent research project, dedicated to improving health and wellbeing of children and adults.

Central nervous system disorders, such as brain tumours and epileptic disorders, are among the leading causes of childhood chronic illness-related morbidity and mortality worldwide.  

Thanks to the Good Friday Appeal, the Melbourne Children’s Trial Centre (MCTC) is increasing the capacity to support clinical trials across The Royal Children’s Hospital and Murdoch Children’s Research Institute.

Paediatric acute lymphoblastic leukaemia (ALL) is the most common childhood cancer. Yet, despite the latest in clinical advances, it still remains the leading cause of cancer related death in young people. 

Type 1 diabetes is diagnosed in two to three children per week at The Royal Children’s Hospital (RCH) and is currently incurable. However, thanks to the support of the Good Friday Appeal, a science and research program conducted by the Murdoch Children’s Research Institute (MCRI) and the RCH is offering new hope. 

Children with disability are among the most complex patients at The Royal Children’s Hospital (RCH). This means it is important to develop an innovative and research-based approach when it comes to the management of disability related health and social issues. Thanks to the support of the Good Friday Appeal, the RCH has been able to […]